Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000227158 (LOC644909), described as "Ligand of numb-protein X 1, E3 ubiquitin protein ligase pseudogene," is annotated as a pseudogene in the human genome. Pseudogenes are segments of DNA that resemble functional genes but are non-coding due to disruptive mutations, lack regulatory sequences, or result from genomic rearrangements. As a pseudogene, LOC644909 does not encode a functional protein and is not considered a receptor, enzyme, transporter, or any other classic molecular drug target[1]. This entry is not a drug target due to its pseudogene status, meaning it does not encode a functional product and has no known role as a receptor or in drug mechanism-of-action[1]. No biological function, disease involvement, or pharmacological data are reported for this gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ligand of numb-protein X 1, E3 ubiquitin protein ligase pseudogene.